Latest newsMore newsUnderstanding Behaviour: Molecular, Cellular and Systems Approaches - FENS mini conference - 9th July 2022May 10, 2022 The European Brain and Behaviour Society (EBBS), European Behavioural Pharmacology Society (EBPS), European Molecular and Cellular Cognition Society (EMCCS) and International Behavioural and Neural Genetics Society (IBANGS) have jointly organized a mini conference titled Understanding Behaviour: Molecular, Cellular and Systems Approaches to describe the most innovative theoretical and technical advancements in the field. NeuroBridges2022 | 4-15th September 2022May 10, 2022 The school, taking place in France, will provide an overview of theoretical and experimental frameworks used to study a variety of decision making processes. It will cover different model systems from rodents to humans and a plethora of decision making mechanisms. Upcoming Engaged Researcher TrainingApr 27, 2022 Lots of opportunities to improve your public engagement skills! Women in Neuroscience - apply now!Mar 28, 2022 A new platform to inspire, connect and support female neuroscientists is emerging: WiN UK! They're looking for enthusiastic volunteers to join the team, from students to senior neuroscientists. Wellcome Connecting Science | Molecular Neurodegeneration and Therapeutic ApproachesMar 7, 2022 This popular discussion-based course will provide an overview of the molecular basis of neurodegenerative disorders. 2022 Milner Therapeutics SymposiumFeb 22, 2022 The Milner Therapeutics Institute are hosting their first ever Hybrid Symposium, and will welcome up to 500 delegates in person and also live-stream the event for those who are overseas or unable to attend. Registration to the Symposium is free, and is open to academics and Milner affiliated companies only. Register for FENS 2022!Feb 22, 2022 Get ready for a rich and exciting scientific programme that will give you the chance to discover all the latest scientific and technological developments in Paris, France. Industry funding potentially compromising gambling addiction research, say expertsFeb 22, 2022 Writing in The Lancet Psychiatry, a group of clinicians and scientists set out their priorities for tackling the pervasive problem of gambling addiction, or ‘gambling disorder’. Commercialisation sessions - hosted by Cambridge EnterpriseFeb 22, 2022 Cambridge Enterprise hosts regular commercialisation sessions, via Microsoft Teams, for members of the University interested in commercialising their research. Funding Opportunity - Neurosciences and mental health partnershipFeb 22, 2022 Apply for a grant to support new partnerships between diverse groups of researchers in neurosciences and mental health. BNA-Brain Carer GrantsFeb 14, 2022 The BNA is currently inviting applications for BNA-Brain Carer Grants to help cover expenses associated with caring responsibilities and enable participation in either BNA-hosted or external neuroscience events. Lab-grown ‘mini brains’ hint at treatments for neurodegenerative diseasesOct 27, 2021 Cambridge researchers have developed ‘mini brains’ that allow them to study a fatal and untreatable neurological disorder causing paralysis and dementia – and for the first time have been able to grow these for almost a year. More newsYou can also view the news archive |